Nexira Group has acquired Tournay Biotechnologies, a European company working in the extraction of active botanicals for the nutraceutical and dietary supplements industries.
Tournay Biotechnologies, a family-owned company founded in 1992, has an ISO 22000-certified manufacturing facility located near Bordeaux, France. In addition, the company has a large product portfolio including their flagship brand Exocyan, a product line of cranberry extracts standardized on proanthocyanidines (PACs) content. PACs are condensed tannins, a type of flavonoid, with antioxidant and other health activities.
With this new acquisition, Nexira expands its range of ingredients and reinforces its positioning towards the health and wellness market, which will soon represent 35% of its commercial activity. Nexira confirms its growth target of €125 million in consolidated sales by 2015.
“We are pleased to welcome the Tournay Biotechnologies personnel, with whom we share family values. We are confident that this acquisition is aligned with the expansion plan that we announced one year ago,” said Stéphane Dondain, President of Nexira.
The transaction terms that will be finalized at the end of October are not disclosed.